What is the mechanism whereby cannabis use increases risk of psychosis? (Q34900815)

5 August 2017

1 reference

title

What is the mechanism whereby cannabis use increases risk of psychosis? (English)

1 reference

5 August 2017

1 reference

Sonija Luzi

1

0 references

Robin Murray

object named as

Robin M Murray

5

0 references

author name string

Paul D Morrison

2

1 reference

5 August 2017

John Powell

3

1 reference

5 August 2017

Marta di Forti

4

1 reference

5 August 2017

publication date

1 October 2008

1 reference

5 August 2017

published in

Neurotoxicity Research

1 reference

5 August 2017

volume

14

1 reference

5 August 2017

issue

2-3

1 reference

5 August 2017

page(s)

105-112

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033802

5 August 2017

exact match

0 references

cites work

Role of endogenous cannabinoids in synaptic signaling

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03033802

Evidence that three dimensions of psychosis have a distribution in the general population.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03033802

Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds

21 January 2018

1 reference

12 December 2020

Altering cannabinoid signaling during development disrupts neuronal activity

1 reference

12 December 2020

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

12 December 2020

No association of CNR1 gene variations with susceptibility to schizophrenia.

1 reference

12 December 2020

Endocannabinoid functions controlling neuronal specification during brain development

1 reference

12 December 2020

Hardwiring the brain: endocannabinoids shape neuronal connectivity

1 reference

12 December 2020

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

12 December 2020

Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring

1 reference

12 December 2020

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

1 reference

12 December 2020

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

12 December 2020

Is heterosynaptic modulation essential for stabilizing Hebbian plasticity and memory?

1 reference

12 December 2020

Antipsychotic effect of cannabidiol.

1 reference

12 December 2020

Effects of prenatal marijuana exposure on child behavior problems at age 10

1 reference

12 December 2020

Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning

1 reference

12 December 2020

The emerging functions of endocannabinoid signaling during CNS development.

1 reference

12 December 2020

The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum

1 reference

12 December 2020

Prenatal marijuana and alcohol exposure and academic achievement at age 10.

1 reference

12 December 2020

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

1 reference

12 December 2020

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

12 December 2020

Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.

1 reference

12 December 2020

Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14.

1 reference

12 December 2020

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

1 reference

12 December 2020

Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia

1 reference

12 December 2020

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia

1 reference

12 December 2020

Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring

1 reference

12 December 2020

Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release

1 reference

12 December 2020

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.

1 reference

12 December 2020

Cannabis use and outcome of recent onset psychosis

1 reference

12 December 2020

Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis

1 reference

12 December 2020

Causal association between cannabis and psychosis: examination of the evidence

1 reference

12 December 2020

Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

12 December 2020

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

1 reference

12 December 2020

A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol

1 reference

12 December 2020

A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function

1 reference

12 December 2020

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

1 reference

12 December 2020

A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia

1 reference

12 December 2020

Cannabidiol monotherapy for treatment-resistant schizophrenia

1 reference

12 December 2020

Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood.

1 reference

12 December 2020

Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age.

1 reference

12 December 2020

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

1 reference

12 December 2020

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

1 reference

12 December 2020

The environment and schizophrenia: the role of cannabis use.

1 reference

12 December 2020

Cannabis dependence and psychotic symptoms in young people

1 reference

12 December 2020

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

12 December 2020

Effects of cannabidiol in animal models predictive of antipsychotic activity

1 reference

12 December 2020

Conceptual issues in behavioral teratology and their application in determining long-term sequelae of prenatal marihuana exposure

1 reference

12 December 2020

The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells.

1 reference

12 December 2020

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

12 December 2020

Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033802

1 reference

Dimensions Publication ID

5 August 2017

1024374276

0 references

1 reference